Skip to main content
SpringerLink
Log in

Utilization of Radiation for Pediatric Hodgkin Lymphoma

  • Chapter
  • First Online:
Pediatric Radiation Oncology

Part of the book series: Pediatric Oncology ((PEDIATRICO))

Abstract

Pediatric Hodgkin lymphoma (PHL) remains one of the great medical success stories of the last century whereby a previously incurable malignancy is now cured in more than 85% of the cases with chemotherapy and radiation. Yet this success in curing PHL has led to the discovery of treatment-related toxicities among survivors decades after treatment, especially with regard to cardiac toxicity and secondary cancers. Consequently, the focus of research in PHL over the last 2–3 decades has been on finding ways to de-escalate therapy and reduce the risk of late toxicities while maintaining high cure rates. Herein, we present the basic epidemiology for PHL and the more recent clinical studies that have impacted the field. Additionally, we present a thorough explanation of modern treatment fields and the current implementation of involved-site radiotherapy in the management of PHL.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution

Institutional subscriptions

References

  • Aznar MC, Maraldo MV, Schut DA, Lundemann M, Brodin NP, Vogelius IR, Berthelsen AK, Specht L, Petersen PM (2015) Minimizing late effects for patients with mediastinal Hodgkin lymphoma: deep inspiration breath-hold, IMRT, or both? Int J Radiat Oncol Biol Phys 92:169–174

    Article  PubMed  Google Scholar 

  • Banerjee D (2011) Recent advances in the pathobiology of Hodgkin’s lymphoma: potential impact on diagnostic, predictive, and therapeutic strategies. Adv Hematol 2011:439456

    Article  PubMed  PubMed Central  Google Scholar 

  • Barrington SF, Mikhaeel NG, Kostakoglu L, Meignan M, Hutchings M, Mueller SP, Schwartz LH, Zucca E, Fisher RI, Trotman J, Hoekstra OS, Hicks RJ, O’Doherty MJ, Hustinx R, Biggi A, Cheson BD (2014) Role of imaging in the staging and response assessment of lymphoma: consensus of the international conference on Malignant Lymphomas Imaging Working Group. J Clin Oncol 32:3048–3058

    Article  PubMed  PubMed Central  Google Scholar 

  • Bhatti P, Veiga LH, Ronckers CM, Sigurdson AJ, Stovall M, Smith SA, Weathers R, Leisenring W, Mertens AC, Hammond S, Friedman DL, Neglia JP, Meadows AT, Donaldson SS, Sklar CA, Robison LL, Inskip PD (2010) Risk of second primary thyroid cancer after radiotherapy for a childhood cancer in a large cohort study: an update from the childhood cancer survivor study. Radiat Res 174:741–752

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Bobrove AM (1983) Alcohol-related pain and Hodgkin’s disease. West J Med 138:874–875

    CAS  PubMed  PubMed Central  Google Scholar 

  • Bolling T, Geisenheiser A, Pape H, Martini C, Rube C, Timmermann B, Fischedick K, Kortmann RD, Gerss J, Koch R, Willich N (2011) Hypothyroidism after head-and-neck radiotherapy in children and adolescents: preliminary results of the “Registry for the Evaluation of Side Effects After Radiotherapy in Childhood and Adolescence” (RiSK). Int J Radiat Oncol Biol Phys 81:e787–e791

    Article  PubMed  Google Scholar 

  • Carbone PP, Kaplan HS, Musshoff K, Smithers DW, Tubiana M (1971) Report of the committee on Hodgkin’s disease staging classification. Cancer Res 31:1860–1861

    CAS  PubMed  Google Scholar 

  • Castellino SM, Geiger AM, Mertens AC, Leisenring WM, Tooze JA, Goodman P, Stovall M, Robison LL, Hudson MM (2011) Morbidity and mortality in long-term survivors of Hodgkin lymphoma: a report from the Childhood Cancer Survivor Study. Blood 117:1806–1816

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Cella L, Conson M, Caterino M, de Rosa N, Liuzzi R, Picardi M, Grimaldi F, Solla R, Farella A, Salvatore M, Pacelli R (2012) Thyroid V30 predicts radiation-induced hypothyroidism in patients treated with sequential chemo-radiotherapy for Hodgkin’s lymphoma. Int J Radiat Oncol Biol Phys 82:1802–1808

    Article  PubMed  Google Scholar 

  • Cella L, Conson M, Pressello MC, Molinelli S, Schneider U, Donato V, Orecchia R, Salvatore M, Pacelli R (2013) Hodgkin’s lymphoma emerging radiation treatment techniques: trade-offs between late radio-induced toxicities and secondary malignant neoplasms. Radiat Oncol 8:22

    Article  PubMed  PubMed Central  Google Scholar 

  • Cella L, Liuzzi R, D’Avino V, Conson M, di Biase A, Picardi M, Pugliese N, Solla R, Salvatore M, Pacelli R (2014) Pulmonary damage in Hodgkin’s lymphoma patients treated with sequential chemo-radiotherapy: predictors of radiation-induced lung injury. Acta Oncol 53:613–619

    Article  CAS  PubMed  Google Scholar 

  • Charpentier AM, Conrad T, Sykes J, Ng A, Zhou R, Parent A, Coolens C, Tsang RW, Gospodarowicz MK, Sun A, Hodgson DC (2014) Active breathing control for patients receiving mediastinal radiation therapy for lymphoma: impact on normal tissue dose. Pract Radiat Oncol 4:174–180

    Article  PubMed  Google Scholar 

  • Cheng G, Chen W, Chamroonrat W, Torigian DA, Zhuang H, Alavi A (2011) Biopsy versus FDG PET/CT in the initial evaluation of bone marrow involvement in pediatric lymphoma patients. Eur J Nucl Med Mol Imaging 38:1469–1476

    Article  PubMed  Google Scholar 

  • Chen-Liang TH, Martin-Santos T, Jerez A, Senent L, Orero MT, Remigia MJ, Muina B, Romera M, Fernandez-Munoz H, Raya JM, Fernandez-Gonzalez M, Lancharro A, Villegas C, Carlos Herrera J, Frutos L, Luis Navarro J, Una J, Igua C, Sanchez-Vano R, Cozar Mdel P, Contreras J, Sanchez-Blanco JJ, Perez-Ceballos E, Ortuno FJ (2015) The role of bone marrow biopsy and FDG-PET/CT in identifying bone marrow infiltration in the initial diagnosis of high grade non-Hodgkin B-cell lymphoma and Hodgkin lymphoma. Accuracy in a multicenter series of 372 patients. Am J Hematol 90:686–690

    Article  CAS  PubMed  Google Scholar 

  • Cheson BD, Fisher RI, Barrington SF, Cavalli F, Schwartz LH, Zucca E, Lister TA (2014) Recommendations for initial evaluation, staging, and response assessment of Hodgkin and non-Hodgkin lymphoma: the Lugano classification. J Clin Oncol 32:3059–3068

    Article  PubMed  PubMed Central  Google Scholar 

  • Childhood Hodgkin Lymphoma Treatment–for health professionals (PDQ®) [Online] (2016) NIH National Cancer Institute Available: http://www.cancer.gov/types/lymphoma/hp/child-hodgkin-treatment-pdq. Accessed 14 Jan 2016

  • Chung CS, Yock TI, Nelson K, Xu Y, Keating NL, Tarbell NJ (2013) Incidence of second malignancies among patients treated with proton versus photon radiation. Int J Radiat Oncol Biol Phys 87:46–52

    Article  CAS  PubMed  Google Scholar 

  • Claviez A, Tiemann M, Luders H, Krams M, Parwaresch R, Schellong G, Dorffel W (2005) Impact of latent Epstein-Barr virus infection on outcome in children and adolescents with Hodgkin’s lymphoma. J Clin Oncol 23:4048–4056

    Article  PubMed  Google Scholar 

  • Das DK, Francis IM, Sharma PN, Sathar SA, John B, George SS, Mallik MK, Sheikh ZA, Haji BE, Pathan SK, Madda JP, Mirza K, Ahmed MS, Junaid TA (2009) Hodgkin’s lymphoma: diagnostic difficulties in fine-needle aspiration cytology. Diagn Cytopathol 37:564–573

    Article  PubMed  Google Scholar 

  • De Bruin ML, Sparidans J, Van’t Veer MB, Noordijk EM, Louwman MW, Zijlstra JM, van den Berg H, Russell NS, Broeks A, Baaijens MH, Aleman BM, van Leeuwen FE (2009) Breast cancer risk in female survivors of Hodgkin’s lymphoma: lower risk after smaller radiation volumes. J Clin Oncol 27:4239–4246

    Article  PubMed  Google Scholar 

  • Donaldson SS, Link MP, Weinstein HJ, Rai SN, Brain S, Billett AL, Hurwitz CA, Krasin M, Kun LE, Marcus KC, Tarbell NJ, Young JA, Hudson MM (2007) Final results of a prospective clinical trial with VAMP and low-dose involved-field radiation for children with low-risk Hodgkin’s disease. J Clin Oncol 25:332–337

    Article  CAS  PubMed  Google Scholar 

  • Dorffel W, Ruhl U, Luders H, Claviez A, Albrecht M, Bokkerink J, Holte H, Karlen J, Mann G, Marciniak H, Niggli F, Schmiegelow K, Schwarze EW, Potter R, Wickmann L, Schellong G (2013) Treatment of children and adolescents with Hodgkin lymphoma without radiotherapy for patients in complete remission after chemotherapy: final results of the multinational trial GPOH-HD95. J Clin Oncol 31:1562–1568

    Article  PubMed  Google Scholar 

  • Elkin EB, Klem ML, Gonzales AM, Ishill NM, Hodgson D, Ng AK, Marks LB, Weidhaas J, Freedman GM, Miller RC, Constine LS, Myrehaug S, Yahalom J (2011) Characteristics and outcomes of breast cancer in women with and without a history of radiation for Hodgkin’s lymphoma: a multi-institutional, matched cohort study. J Clin Oncol 29:2466–2473

    Article  PubMed  PubMed Central  Google Scholar 

  • Evens AM, Kostakoglu L (2014) The role of FDG-PET in defining prognosis of Hodgkin lymphoma for early-stage disease. Hematology/the education program of the American Society of Hematology. American Society of Hematology. Educ Program 2014:135–143

    Google Scholar 

  • Feng M, Moran JM, Koelling T, Chughtai A, Chan JL, Freedman L, Hayman JA, Jagsi R, Jolly S, Larouere J, Soriano J, Marsh R, Pierce LJ (2011) Development and validation of a heart atlas to study cardiac exposure to radiation following treatment for breast cancer. Int J Radiat Oncol Biol Phys 79:10–18

    Article  PubMed  Google Scholar 

  • Flavell KJ, Murray PG (2000) Hodgkin’s disease and the Epstein-Barr virus. Mol Pathol 53:262–269

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Fox AM, Dosoretz AP, Mauch PM, Chen YH, Fisher DC, Lacasce AS, Freedman AS, Silver B, Ng AK (2012) Predictive factors for radiation pneumonitis in Hodgkin lymphoma patients receiving combined-modality therapy. Int J Radiat Oncol Biol Phys 83:277–283

    Article  PubMed  Google Scholar 

  • Friedman DL, Chen L, Wolden S, Buxton A, Mccarten K, Fitzgerald TJ, Kessel S, de Alarcon PA, Chen AR, Kobrinsky N, Ehrlich P, Hutchison RE, Constine LS, Schwartz CL (2014) Dose-intensive response-based chemotherapy and radiation therapy for children and adolescents with newly diagnosed intermediate-risk hodgkin lymphoma: a report from the Children’s Oncology Group Study AHOD0031. J Clin Oncol 32:3651–3658

    Article  PubMed  PubMed Central  Google Scholar 

  • Furst CJ, Lundell M, Ahlback SO, Holm LE (1989) Breast hypoplasia following irradiation of the female breast in infancy and early childhood. Acta Oncol 28:519–523

    Article  CAS  PubMed  Google Scholar 

  • Gallamini A, Hutchings M, Rigacci L, Specht L, Merli F, Hansen M, Patti C, Loft A, di Raimondo F, D’Amore F, Biggi A, Vitolo U, Stelitano C, Sancetta R, Trentin L, Luminari S, Iannitto E, Viviani S, Pierri I, Levis A (2007) Early interim 2-[18F]fluoro-2-deoxy-D-glucose positron emission tomography is prognostically superior to international prognostic score in advanced-stage Hodgkin’s lymphoma: a report from a joint Italian-Danish study. J Clin Oncol 25:3746–3752

    Article  CAS  PubMed  Google Scholar 

  • Hancock SL, Tucker MA, Hoppe RT (1993) Factors affecting late mortality from heart disease after treatment of Hodgkin’s disease. JAMA 270:1949–1955

    Article  CAS  PubMed  Google Scholar 

  • Henry-Amar M, Friedman S, Hayat M, Somers R, Meerwaldt JH, Carde P, Burgers JM, Thomas J, Monconduit M, Noordijk EM et al (1991) Erythrocyte sedimentation rate predicts early relapse and survival in early-stage Hodgkin disease. The EORTC Lymphoma Cooperative Group. Ann Intern Med 114:361–365

    Article  CAS  PubMed  Google Scholar 

  • Hines-Thomas MR, Howard SC, Hudson MM, Krasin MJ, Kaste SC, Shulkin BL, Metzger ML (2010) Utility of bone marrow biopsy at diagnosis in pediatric Hodgkin’s lymphoma. Haematologica 95:1691–1696

    Article  PubMed  PubMed Central  Google Scholar 

  • Hodgson DC, Dieckmann K, Terezakis S, Constine L (2015) Implementation of contemporary radiation therapy planning concepts for pediatric Hodgkin lymphoma: guidelines from the International Lymphoma Radiation Oncology Group. Pract Radiat Oncol 5:85–92

    Article  PubMed  Google Scholar 

  • Hohaus S, Massini G, Giachelia M, Vannata B, Bozzoli V, Cuccaro A, D’Alo F, Larocca LM, Raymakers RA, Swinkels DW, Voso MT, Leone G (2010) Anemia in Hodgkin’s lymphoma: the role of interleukin-6 and hepcidin. J Clin Oncol 28:2538–2543

    Article  CAS  PubMed  Google Scholar 

  • Hoppe RT, Mauch PT, Armitage JO, Diehl V, Weiss LM (2007) Hodgkin lymphoma. Lippincott Williams & Wilkins, Philadelphia, PA

    Google Scholar 

  • Hoppe BS, Flampouri S, Su Z, Latif N, Dang NH, Lynch J, Joyce M, Sandler E, Li Z, Mendenhall NP (2012a) Effective dose reduction to cardiac structures using protons compared with 3DCRT and IMRT in mediastinal Hodgkin lymphoma. Int J Radiat Oncol Biol Phys 84:449–455

    Article  PubMed  Google Scholar 

  • Hoppe BS, Flampouri S, Su Z, Morris CG, Latif N, Dang NH, Lynch J, Li Z, Mendenhall NP (2012b) Consolidative involved-node proton therapy for Stage IA-IIIB mediastinal Hodgkin lymphoma: preliminary dosimetric outcomes from a Phase II study. Int J Radiat Oncol Biol Phys 83:260–267

    Article  PubMed  Google Scholar 

  • Hoppe BS, Flampouri S, Zaiden R, Slayton W, Sandler E, Ozdemir S, Dang NH, Lynch JW, Li Z, Morris CG, Mendenhall NP (2014) Involved-node proton therapy in combined modality therapy for Hodgkin lymphoma: results of a phase 2 study. Int J Radiat Oncol Biol Phys 89:1053–1059

    Article  PubMed  Google Scholar 

  • Hua C, Hoth KA, Wu S, Kun LE, Metzger ML, Spunt SL, Xiong X, Krasin MJ (2010) Incidence and correlates of radiation pneumonitis in pediatric patients with partial lung irradiation. Int J Radiat Oncol Biol Phys 78:143–149

    Article  PubMed  PubMed Central  Google Scholar 

  • Hull MC, Morris CG, Pepine CJ, Mendenhall NP (2003) Valvular dysfunction and carotid, subclavian, and coronary artery disease in survivors of hodgkin lymphoma treated with radiation therapy. JAMA 290:2831–2837

    Article  CAS  PubMed  Google Scholar 

  • Hutchings M, Loft A, Hansen M, Pedersen LM, Buhl T, Jurlander J, Buus S, Keiding S, D’Amore F, Boesen AM, Berthelsen AK, Specht L (2006) FDG-PET after two cycles of chemotherapy predicts treatment failure and progression-free survival in Hodgkin lymphoma. Blood 107:52–59

    Article  CAS  PubMed  Google Scholar 

  • Hutchinson RJ, Fryer CJ, Davis PC, Nachman J, Krailo MD, O’Brien RT, Collins RD, Whalen T, Reardon D, Trigg ME, Gilchrist GS (1998) MOPP or radiation in addition to ABVD in the treatment of pathologically staged advanced Hodgkin’s disease in children: results of the Children’s Cancer Group Phase III trial. J Clin Oncol 16:897–906

    Article  CAS  PubMed  Google Scholar 

  • Iberri DJ, Hoppe RT, Advani RH (2015) Hodgkin lymphoma: the changing role of radiation therapy in early-stage disease-the role of functional imaging. Curr Treat Options in Oncol 16:45

    Article  Google Scholar 

  • Ilivitzki A, Radan L, Ben-Arush M, Israel O, Ben-Barak A (2013) Early interim FDG PET/CT prediction of treatment response and prognosis in pediatric Hodgkin disease-added value of low-dose CT. Pediatr Radiol 43:86–92

    Article  PubMed  Google Scholar 

  • Jarrett RF, Stark GL, White J, Angus B, Alexander FE, Krajewski AS, Freeland J, Taylor GM, Taylor PR (2005) Impact of tumor Epstein-Barr virus status on presenting features and outcome in age-defined subgroups of patients with classic Hodgkin lymphoma: a population-based study. Blood 106:2444–2451

    Article  CAS  PubMed  Google Scholar 

  • Kamal NM, Elsaban K (2014) Role of 18f-fdg-pet/ct in assessment of pediatric Hodgkin’s lymphoma. Q J Nucl Med Mol Imaging

    Google Scholar 

  • Keegan TH, Glaser SL, Clarke CA, Gulley ML, Craig FE, Digiuseppe JA, Dorfman RF, Mann RB, Ambinder RF (2005) Epstein-Barr virus as a marker of survival after Hodgkin’s lymphoma: a population-based study. J Clin Oncol 23:7604–7613

    Article  PubMed  Google Scholar 

  • Keller FG, Nachman J, Constine L, Thomson J, Mccarten K, Chen L, Schwartz C (2010) A phase III study for the treatment of children and adolescents with newly diagnosed low risk Hodgkin lymphoma (HL). In: 53rd ASH annual meeting and exposition, Orlando, FL

    Google Scholar 

  • Kelly KM (2012) Management of children with high-risk Hodgkin lymphoma. Br J Haematol 157:3–13

    Article  CAS  PubMed  Google Scholar 

  • Kelly KM, Cole PD, Chen L, Roberts KB, Hodgson DC, Mccarten K et al (2015) Phase III study of response adapted therapy for the treatment of children with newly diagnosed very high risk Hodgkin lymphoma (Stages IIIB/IVB) (AHOD0831): a report from the Children’s Oncology Group. In: 57th ASH annual meeting & exposition, Orlando, FL

    Google Scholar 

  • Kharazmi E, Fallah M, Pukkala E, Olsen JH, Tryggvadottir L, Sundquist K, Tretli S, Hemminki K (2015) Risk of familial classical Hodgkin lymphoma by relationship, histology, age, and sex: a joint study from five Nordic countries. Blood 126:1990–1995

    Article  CAS  PubMed  Google Scholar 

  • Kung FH, Schwartz CL, Ferree CR, London WB, Ternberg JL, Behm FG, Wharam MD, Falletta JM, de Alarcon P, Chauvenet AR (2006) POG 8625: a randomized trial comparing chemotherapy with chemoradiotherapy for children and adolescents with Stages I, IIA, IIIA1 Hodgkin Disease: a report from the Children’s Oncology Group. J Pediatr Hematol Oncol 28:362–368

    Article  CAS  PubMed  Google Scholar 

  • Kuppers R, Schwering I, Brauninger A, Rajewsky K, Hansmann ML (2002) Biology of Hodgkin’s lymphoma. Ann Oncol 13(Suppl 1):11–18

    Article  PubMed  Google Scholar 

  • Kurzrock R, Redman J, Cabanillas F, Jones D, Rothberg J, Talpaz M (1993) Serum interleukin 6 levels are elevated in lymphoma patients and correlate with survival in advanced Hodgkin’s disease and with B symptoms. Cancer Res 53:2118–2122

    CAS  PubMed  Google Scholar 

  • Landman-Parker J, Pacquement H, Leblanc T, Habrand JL, Terrier-Lacombe MJ, Bertrand Y, Perel Y, Robert A, Coze C, Thuret I, Donadieu J, Schaison G, Leverger G, Lemerle J, Oberlin O (2000) Localized childhood Hodgkin’s disease: response-adapted chemotherapy with etoposide, bleomycin, vinblastine, and prednisone before low-dose radiation therapy-results of the French Society of Pediatric Oncology Study MDH90. J Clin Oncol 18:1500–1507

    Article  CAS  PubMed  Google Scholar 

  • Lee JH, Kim Y, Choi JW, Kim YS (2014) Prevalence and prognostic significance of Epstein-Barr virus infection in classical Hodgkin’s lymphoma: a meta-analysis. Arch Med Res 45:417–431

    Article  PubMed  Google Scholar 

  • Levine AM (1998) Hodgkin’s disease in the setting of human immunodeficiency virus infection. J Natl Cancer Inst:37–42

    Google Scholar 

  • Linabery AM, Erhardt EB, Richardson MR, Ambinder RF, Friedman DL, Glaser SL, Monnereau A, Spector LG, Ross JA, Grufferman S (2015) Family history of cancer and risk of pediatric and adolescent Hodgkin lymphoma: a Children’s Oncology Group study. Int J Cancer 137:2163–2174

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Long-term follow-up guidelines for survivors of childhood, adolescent, and young adult cancers [Online] (2014) Children’s Oncology Group. Available: http://www.survivorshipguidelines.org/

  • Mack TM, Cozen W, Shibata DK, Weiss LM, Nathwani BN, Hernandez AM, Taylor CR, Hamilton AS, Deapen DM, Rappaport EB (1995) Concordance for Hodgkin’s disease in identical twins suggesting genetic susceptibility to the young-adult form of the disease. N Engl J Med 332:413–418

    Article  CAS  PubMed  Google Scholar 

  • Maraldo MV, Brodin NP, Aznar MC, Vogelius IR, Munck Af Rosenschold P, Petersen PM, Specht L (2013a) Estimated risk of cardiovascular disease and secondary cancers with modern highly conformal radiotherapy for early-stage mediastinal Hodgkin lymphoma. Ann Oncol 24:2113–2118

    Article  CAS  PubMed  Google Scholar 

  • Maraldo MV, Brodin P, Aznar MC, Vogelius IR, Munck Af Rosenschold P, Petersen PM, Specht L (2013b) Doses to carotid arteries after modern radiation therapy for Hodgkin lymphoma: is stroke still a late effect of treatment? Int J Radiat Oncol Biol Phys 87:297–303

    Article  PubMed  Google Scholar 

  • Maraldo MV, Brodin NP, Aznar MC, Vogelius IR, Munck Af Rosenschold P, Petersen PM, Specht L (2014) Doses to head and neck normal tissues for early stage Hodgkin lymphoma after involved node radiotherapy. Radiother Oncol 110:441–447

    Article  CAS  PubMed  Google Scholar 

  • Mauz-Korholz C, Hasenclever D, Dorffel W, Ruschke K, Pelz T, Voigt A, Stiefel M, Winkler M, Vilser C, Dieckmann K, Karlen J, Bergstrasser E, Fossa A, Mann G, Hummel M, Klapper W, Stein H, Vordermark D, Kluge R, Korholz D (2010) Procarbazine-free OEPA-COPDAC chemotherapy in boys and standard OPPA-COPP in girls have comparable effectiveness in pediatric Hodgkin’s lymphoma: the GPOH-HD-2002 study. J Clin Oncol 28:3680–3686

    Article  PubMed  Google Scholar 

  • Metzger ML, Castellino SM, Hudson MM, Rai SN, Kaste SC, Krasin MJ, Kun LE, Pui CH, Howard SC (2008) Effect of race on the outcome of pediatric patients with Hodgkin’s lymphoma. J Clin Oncol 26:1282–1288

    Article  PubMed  Google Scholar 

  • Metzger ML, Weinstein HJ, Hudson MM, Billett AL, Larsen EC, Friedmann A, Howard SC, Donaldson SS, Krasin MJ, Kun LE, Marcus KJ, Yock TI, Tarbell N, Billups CA, Wu J, Link MP (2012) Association between radiotherapy vs no radiotherapy based on early response to VAMP chemotherapy and survival among children with favorable-risk Hodgkin lymphoma. JAMA 307:2609–2616

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Miller E, Metser U, Avrahami G, Dvir R, Valdman D, Sira LB, Sayar D, Burstein Y, Toren A, Yaniv I, Even-Sapir E (2006) Role of 18F-FDG PET/CT in staging and follow-up of lymphoma in pediatric and young adult patients. J Comput Assist Tomogr 30:689–694

    Article  PubMed  Google Scholar 

  • Morton LM, Dores GM, Curtis RE, Lynch CF, Stovall M, Hall P, Gilbert ES, Hodgson DC, Storm HH, Johannesen TB, Smith SA, Weathers RE, Andersson M, Fossa SD, Hauptmann M, Holowaty EJ, Joensuu H, Kaijser M, Kleinerman RA, Langmark F, Pukkala E, Vaalavirta L, van den Belt-Dusebout AW, Fraumeni JF Jr, Travis LB, Aleman BM, van Leeuwen FE (2013) Stomach cancer risk after treatment for hodgkin lymphoma. J Clin Oncol 31:3369–3377

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Mulrooney DA, Yeazel MW, Kawashima T, Mertens AC, Mitby P, Stovall M, Donaldson SS, Green DM, Sklar CA, Robison LL, Leisenring WM (2009) Cardiac outcomes in a cohort of adult survivors of childhood and adolescent cancer: retrospective analysis of the Childhood Cancer Survivor Study cohort. BMJ 339:b4606

    Article  PubMed  PubMed Central  Google Scholar 

  • Nachman JB, Sposto R, Herzog P, Gilchrist GS, Wolden SL, Thomson J, Kadin ME, Pattengale P, Davis PC, Hutchinson RJ, White K (2002) Randomized comparison of low-dose involved-field radiotherapy and no radiotherapy for children with Hodgkin’s disease who achieve a complete response to chemotherapy. J Clin Oncol 20:3765–3771

    Article  PubMed  Google Scholar 

  • Neglia JP, Robison LL, Stovall M, Liu Y, Packer RJ, Hammond S, Yasui Y, Kasper CE, Mertens AC, Donaldson SS, Meadows AT, Inskip PD (2006) New primary neoplasms of the central nervous system in survivors of childhood cancer: a report from the Childhood Cancer Survivor Study. J Natl Cancer Inst 98:1528–1537

    Article  PubMed  Google Scholar 

  • Ng AK, Bernardo MP, Weller E, Backstrand KH, Silver B, Marcus KC, Tarbell NJ, Friedberg J, Canellos GP, Mauch PM (2002) Long-term survival and competing causes of death in patients with early-stage Hodgkin’s disease treated at age 50 or younger. J Clin Oncol 20:2101–2108

    Article  PubMed  Google Scholar 

  • Paulino AC, Margolin J, Dreyer Z, Teh BS, Chiang S (2012) Impact of PET-CT on involved field radiotherapy design for pediatric Hodgkin lymphoma. Pediatr Blood Cancer 58:860–864

    Article  PubMed  Google Scholar 

  • Paumier A, Bakkour M, Ghalibafian M, Beaudre A, Blanchard P, Martinetti F, Girinsky T (2012) Involved-node radiotherapy combined with deep-inspiration breath-hold technique in patients with Hodgkin lymphoma. Cancer Radiother 16:85–90

    Article  CAS  PubMed  Google Scholar 

  • PDQ Cancer Information Summaries (2016). National Cancer Institute (US). http://www.ncbi.nlm.nih.gov/books/NBK82221/

  • Pileri SA, Ascani S, Leoncini L, Sabattini E, Zinzani PL, Piccaluga PP, Pileri A Jr, Giunti M, Falini B, Bolis GB, Stein H (2002) Hodgkin’s lymphoma: the pathologist’s viewpoint. J Clin Pathol 55:162–176

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Podda MG, Terenziani M, Gandola L, Collini P, Pizzi N, Marchiano A, Morosi C, Luksch R, Ferrari A, Casanova M, Spreafico F, Polastri D, Meazza C, Catania S, Schiavello E, Biassoni V, Massimino M (2014) Thyroid carcinoma after treatment for malignancies in childhood and adolescence: from diagnosis through follow-up. Med Oncol 31:121

    Article  PubMed  Google Scholar 

  • REGIONAL LYMPH NODES. National Institute of Health (US) National Cancer Institute (2016). Available from: http://training.seer.cancer.gov/lymphoma/anatomy/lymph-nodes.html

  • Reynolds GM, Billingham LJ, Gray LJ, Flavell JR, Najafipour S, Crocker J, Nelson P, Young LS, Murray PG (2002) Interleukin 6 expression by Hodgkin/Reed-Sternberg cells is associated with the presence of ‘B’ symptoms and failure to achieve complete remission in patients with advanced Hodgkin’s disease. Br J Haematol 118:195–201

    Article  CAS  PubMed  Google Scholar 

  • Robertson VL, Anderson CS, Keller FG, Halkar R, Goodman M, Marcus RB, Esiashvili N (2011) Role of FDG-PET in the definition of involved-field radiation therapy and management for pediatric Hodgkin’s lymphoma. Int J Radiat Oncol Biol Phys 80:324–332

    Article  PubMed  Google Scholar 

  • Ruhl U, Albrecht M, Dieckmann K, Luders H, Marciniak H, Schellenberg D, Wickmann L, Dorffel W (2001) Response-adapted radiotherapy in the treatment of pediatric Hodgkin’s disease: an interim report at 5 years of the German GPOH-HD 95 trial. Int J Radiat Oncol Biol Phys 51:1209–1218

    Article  CAS  PubMed  Google Scholar 

  • Sachsman S, Hoppe BS, Mendenhall NP, Holtzman A, Li Z, Slayton W, Joyce M, Sandler E, Flampouri S (2015) Proton therapy to the subdiaphragmatic region in the management of patients with Hodgkin lymphoma. Leuk Lymphoma 56:2019–2024

    Article  PubMed  Google Scholar 

  • Schellong G (1996) The balance between cure and late effects in childhood Hodgkin’s lymphoma: the experience of the German-Austrian Study-Group since 1978. German-Austrian Pediatric Hodgkin’s Disease Study Group. Ann Oncol 7(Suppl 4):67–72

    Article  PubMed  Google Scholar 

  • Schellong G, Bramswig JH, Hornig-Franz I, Schwarze EW, Potter R, Wannenmacher M (1994) Hodgkin’s disease in children: combined modality treatment for stages IA, IB, and IIA. Results in 356 patients of the German/Austrian Pediatric Study Group. Ann Oncol 5(Suppl 2):113–115

    Article  PubMed  Google Scholar 

  • Schellong G, Potter R, Bramswig J, Wagner W, Prott FJ, Dorffel W, Korholz D, Mann G, Rath B, Reiter A, Weissbach G, Riepenhausen M, Thiemann M, Schwarze EW (1999) High cure rates and reduced long-term toxicity in pediatric Hodgkin’s disease: the German-Austrian multicenter trial DAL-HD-90. The German-Austrian Pediatric Hodgkin’s Disease Study Group. J Clin Oncol 17:3736–3744

    Article  CAS  PubMed  Google Scholar 

  • Schwartz CL, Constine LS, Villaluna D, London WB, Hutchison RE, Sposto R, Lipshultz SE, Turner CS, Dealarcon PA, Chauvenet A (2009) A risk-adapted, response-based approach using ABVE-PC for children and adolescents with intermediate- and high-risk Hodgkin lymphoma: the results of P9425. Blood 114:2051–2059

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Shankar A, Daw S (2012) Nodular lymphocyte predominant Hodgkin lymphoma in children and adolescents—a comprehensive review of biology, clinical course and treatment options. Br J Haematol 159:288–298

    Article  PubMed  Google Scholar 

  • Skinnider BF, Mak TW (2002) The role of cytokines in classical Hodgkin lymphoma. Blood 99:4283–4297

    Article  CAS  PubMed  Google Scholar 

  • Smith RS, Chen Q, Hudson MM, Link MP, Kun L, Weinstein H, Billett A, Marcus KJ, Tarbell NJ, Donaldson SS (2003) Prognostic factors for children with Hodgkin’s disease treated with combined-modality therapy. J Clin Oncol 21:2026–2033

    Article  PubMed  Google Scholar 

  • Tebbi CK, Mendenhall NP, London WB, Williams JL, Hutchison RE, Fitzgerald TJ, de Alarcon PA, Schwartz C, Chauvenet A (2012) Response-dependent and reduced treatment in lower risk Hodgkin lymphoma in children and adolescents, results of P9426: a report from the Children’s Oncology Group. Pediatr Blood Cancer 59:1259–1265

    Article  PubMed  PubMed Central  Google Scholar 

  • Terezakis SA, Metzger ML, Hodgson DC, Schwartz CL, Advani R, Flowers CR, Hoppe BS, Ng A, Roberts KB, Shapiro R, Wilder RB, Yunes MJ, Constine LS (2014) ACR appropriateness criteria pediatric Hodgkin lymphoma. Pediatr Blood Cancer 61:1305–1312

    Article  PubMed  Google Scholar 

  • Thomas RK, Re D, Zander T, Wolf J, Diehl V (2002) Epidemiology and etiology of Hodgkin’s lymphoma. Ann Oncol 13(Suppl 4):147–152

    Article  PubMed  Google Scholar 

  • Travis LB, Gospodarowicz M, Curtis RE, Clarke EA, Andersson M, Glimelius B, Joensuu T, Lynch CF, van Leeuwen FE, Holowaty E, Storm H, Glimelius I, Pukkala E, Stovall M, Fraumeni JF Jr, Boice JD Jr, Gilbert E (2002) Lung cancer following chemotherapy and radiotherapy for Hodgkin’s disease. J Natl Cancer Inst 94:182–192

    Article  PubMed  Google Scholar 

  • Travis LB, Hill DA, Dores GM, Gospodarowicz M, van Leeuwen FE, Holowaty E, Glimelius B, Andersson M, Wiklund T, Lynch CF, Van’t Veer MB, Glimelius I, Storm H, Pukkala E, Stovall M, Curtis R, Boice JD Jr, Gilbert E (2003) Breast cancer following radiotherapy and chemotherapy among young women with Hodgkin disease. JAMA 290:465–475

    Article  PubMed  Google Scholar 

  • Travis LB, Hill D, Dores GM, Gospodarowicz M, van Leeuwen FE, Holowaty E, Glimelius B, Andersson M, Pukkala E, Lynch CF, Pee D, Smith SA, Van’t Veer MB, Joensuu T, Storm H, Stovall M, Boice JD Jr, Gilbert E, Gail MH (2005) Cumulative absolute breast cancer risk for young women treated for Hodgkin lymphoma. J Natl Cancer Inst 97:1428–1437

    Article  PubMed  Google Scholar 

  • Tukenova M, Guibout C, Hawkins M, Quiniou E, Mousannif A, Pacquement H, Winter D, Bridier A, Lefkopoulos D, Oberlin O, Diallo I, de Vathaire F (2011) Radiation therapy and late mortality from second sarcoma, carcinoma, and hematological malignancies after a solid cancer in childhood. Int J Radiat Oncol Biol Phys 80:339–346

    Article  PubMed  Google Scholar 

  • Tzankov A, Zimpfer A, Pehrs AC, Lugli A, Went P, Maurer R, Pileri S, Dirnhofer S (2003) Expression of B-cell markers in classical hodgkin lymphoma: a tissue microarray analysis of 330 cases. Mod Pathol 16:1141–1147

    Article  PubMed  Google Scholar 

  • Van Nimwegen FA, Schaapveld M, Cutter DJ, Janus CP, Krol AD, Hauptmann M, Kooijman K, Roesink J, van der Maazen R, Darby SC, Aleman BM, van Leeuwen FE (2016) Radiation dose-response relationship for risk of coronary heart disease in survivors of Hodgkin lymphoma. J Clin Oncol 34:235–243

    Article  PubMed  Google Scholar 

  • Vassilakopoulos TP, Angelopoulou MK, Siakantaris MP, Konstantinou N, Symeonidis A, Karmiris T, Repoussis P, Roussou P, Dimopoulos AM, Kokoris SI, Dimitriadou EM, Kyrtsonis MC, Dimopoulou MN, Tsatalas C, Kokkinis G, Vrakidou E, Grigoraki V, Poziopoulos C, Stamatellou M, Liapis D, Georgiou G, Panayiotidis P, Pangalis GA (2006) Pure infradiaphragmatic Hodgkin’s lymphoma. Clinical features, prognostic factor and comparison with supradiaphragmatic disease. Haematologica 91:32–39

    PubMed  Google Scholar 

  • Veiga LH, Lubin JH, Anderson H, de Vathaire F, Tucker M, Bhatti P, Schneider A, Johansson R, Inskip P, Kleinerman R, Shore R, Pottern L, Holmberg E, Hawkins MM, Adams MJ, Sadetzki S, Lundell M, Sakata R, Damber L, Neta G, Ron E (2012) A pooled analysis of thyroid cancer incidence following radiotherapy for childhood cancer. Radiat Res 178:365–376

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Voss SD, Chen L, Constine LS, Chauvenet A, Fitzgerald TJ, Kaste SC, Slovis T, Schwartz CL (2012) Surveillance computed tomography imaging and detection of relapse in intermediate- and advanced-stage pediatric Hodgkin’s lymphoma: a report from the Children’s Oncology Group. J Clin Oncol 30:2635–2640

    Article  PubMed  PubMed Central  Google Scholar 

  • Ward E, Desantis C, Robbins A, Kohler B, Jemal A (2014) Childhood and adolescent cancer statistics, 2014. CA Cancer J Clin 64:83–103

    Article  PubMed  Google Scholar 

  • Weber DC, Johanson S, Peguret N, Cozzi L, Olsen DR (2011) Predicted risk of radiation-induced cancers after involved field and involved node radiotherapy with or without intensity modulation for early-stage hodgkin lymphoma in female patients. Int J Radiat Oncol Biol Phys 81:490–497

    Article  PubMed  Google Scholar 

  • Weiner MA, Leventhal B, Brecher ML, Marcus RB, Cantor A, Gieser PW, Ternberg JL, Behm FG, Wharam MD Jr, Chauvenet AR (1997) Randomized study of intensive MOPP-ABVD with or without low-dose total-nodal radiation therapy in the treatment of stages IIB, IIIA2, IIIB, and IV Hodgkin’s disease in pediatric patients: a Pediatric Oncology Group study. J Clin Oncol 15:2769–2779

    Article  CAS  PubMed  Google Scholar 

  • Westergaard T, Melbye M, Pedersen JB, Frisch M, Olsen JH, Andersen PK (1997) Birth order, sibship size and risk of Hodgkin’s disease in children and young adults: a population-based study of 31 million person-years. Int J Cancer 72:977–981

    Article  CAS  PubMed  Google Scholar 

  • Wolden SL, Chen L, Kelly KM, Herzog P, Gilchrist GS, Thomson J, Sposto R, Kadin ME, Hutchinson RJ, Nachman J (2012) Long-term results of CCG 5942: a randomized comparison of chemotherapy with and without radiotherapy for children with Hodgkin’s lymphoma—a report from the Children’s Oncology Group. J Clin Oncol 30:3174–3180

    Article  PubMed  PubMed Central  Google Scholar 

  • Wray J, Hoppe BS, Flampouri S, Morris CG, Slayton W, Joyce M, Sandler E, Li Z, Indelicato DJ, Mendenhall NP (2014) Proton Therapy for Pediatric Hodgkin Lymphoma. Int J Particle Ther 2:61

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Radiation Oncology, University of Florida, 2015 North Jefferson St., Jacksonville, FL, 32206, USA

    Bradford S. Hoppe M.D., M.P.H.

  2. Department of Radiation Oncology, Moffitt Cancer Center, 12902 USF Magnolia Drive, Tampa, FL, 33612, USA

    Ronica H. Nanda M.D.

  3. Department of Radiation Oncology, Centre Hospitalier de l’Université de Montréal, 1000 St-Denis St., Montreal, QC, H2X 3J4, Canada

    Anne-Marie Charpentier M.D., F.R.C.P.C.

Authors
  1. Bradford S. Hoppe M.D., M.P.H.
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Ronica H. Nanda M.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Anne-Marie Charpentier M.D., F.R.C.P.C.
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Bradford S. Hoppe M.D., M.P.H. .

Editor information

Editors and Affiliations

  1. Department of Radiation Oncology, St Jude Children’s Research Hospital, Memphis, Tennessee, USA

    Thomas E. Merchant

  2. Department of Radiation Oncology, University of Leipzig, Leipzig, Germany

    Rolf-Dieter Kortmann

Rights and permissions

Reprints and permissions

Copyright information

© 2018 Springer International Publishing Switzerland

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Hoppe, B.S., Nanda, R.H., Charpentier, AM. (2018). Utilization of Radiation for Pediatric Hodgkin Lymphoma. In: Merchant, T., Kortmann, RD. (eds) Pediatric Radiation Oncology. Pediatric Oncology. Springer, Cham. https://doi.org/10.1007/978-3-319-43545-9_15

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-43545-9_15

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-43544-2

  • Online ISBN: 978-3-319-43545-9

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation